Reply to: On meta-analytic models and the effect of hydroxychloroquine use in COVID-19.
作者信息
Schmitt Andreas M, Axfors Cathrine, Moher David, Goodman Steven N, Ioannidis John P A, Hemkens Lars G
机构信息
Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
Department of Medical Oncology, University Hospital Basel, Basel, Switzerland.
出版信息
Nat Commun. 2025 Jul 11;16(1):6354. doi: 10.1038/s41467-025-60479-w.
Abstract
摘要
相似文献
1
Reply to: On meta-analytic models and the effect of hydroxychloroquine use in COVID-19.
Nat Commun. 2025 Jul 11;16(1):6354. doi: 10.1038/s41467-025-60479-w.
2
Comprehensive analysis of gastrointestinal side effects in COVID-19 patients undergoing combined pharmacological treatment with azithromycin and hydroxychloroquine: a systematic review and network meta-analysis.
Crit Rev Toxicol. 2024 Jul;54(6):345-358. doi: 10.1080/10408444.2024.2348169. Epub 2024 Jun 11.
3
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2.
4
Effect of azithromycin and hydroxychloroquine in patients hospitalized with COVID-19: Network meta-analysis of randomized controlled trials.
J Med Virol. 2021 Dec;93(12):6737-6749. doi: 10.1002/jmv.27259. Epub 2021 Aug 17.
5
The PRINCIPLE randomised controlled open label platform trial of hydroxychloroquine for treating COVID19 in community based patients at high risk.
Sci Rep. 2025 Jul 4;15(1):23850. doi: 10.1038/s41598-025-09275-6.
6
Prevalence of increased alcohol use and alcohol use disorders in adult victims of terrorist attacks: a systematic and meta-analytic review.
Am J Drug Alcohol Abuse. 2023 Nov 2;49(6):705-722. doi: 10.1080/00952990.2023.2275526. Epub 2023 Dec 11.
7
The Effect of Hormonal Contraceptive Use on Skeletal Muscle Hypertrophy, Power and Strength Adaptations to Resistance Exercise Training: A Systematic Review and Multilevel Meta-analysis.
Sports Med. 2024 Jan;54(1):105-125. doi: 10.1007/s40279-023-01911-3. Epub 2023 Sep 27.
8
Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis.
PLoS Med. 2020 Dec 30;17(12):e1003501. doi: 10.1371/journal.pmed.1003501. eCollection 2020 Dec.
9
Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.
Health Technol Assess. 2013 Sep;17(43):1-253. doi: 10.3310/hta17430.
10
The impact of influenza and pneumococcal vaccination on antibiotic use: an updated systematic review and meta-analysis.
Antimicrob Resist Infect Control. 2023 Jul 14;12(1):70. doi: 10.1186/s13756-023-01272-6.
本文引用的文献
1
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.
Nat Commun. 2024 Feb 5;15(1):1075. doi: 10.1038/s41467-024-45360-6.
2
Impact of Allocation Concealment and Blinding in Trials Addressing Treatments for COVID-19: A Methods Study.
Am J Epidemiol. 2023 Oct 10;192(10):1678-1687. doi: 10.1093/aje/kwad131.
3
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.
JAMA. 2023 Jan 3;329(1):39-51. doi: 10.1001/jama.2022.23257.
4
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses.
Lancet. 2022 May 21;399(10339):1941-1953. doi: 10.1016/S0140-6736(22)00519-0. Epub 2022 May 2.
5
Hydroxychloroquine versus placebo in the treatment of non-hospitalised patients with COVID-19 (COPE - Coalition V): A double-blind, multicentre, randomised, controlled trial.
Lancet Reg Health Am. 2022 Jul;11:100243. doi: 10.1016/j.lana.2022.100243. Epub 2022 Mar 31.
6
How to Use and Interpret the Results of a Platform Trial: Users' Guide to the Medical Literature.
JAMA. 2022 Jan 4;327(1):67-74. doi: 10.1001/jama.2021.22507.
7
Hydroxychloroquine and mortality in COVID-19 patients: a systematic review and a meta-analysis of observational studies and randomized controlled trials.
Pathog Glob Health. 2021 Oct-Dec;115(7-8):456-466. doi: 10.1080/20477724.2021.1936818. Epub 2021 Jun 15.
8
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.
Nat Commun. 2021 Apr 15;12(1):2349. doi: 10.1038/s41467-021-22446-z.
9
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
Cochrane Database Syst Rev. 2021 Feb 12;2(2):CD013587. doi: 10.1002/14651858.CD013587.pub2.
10
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
N Engl J Med. 2021 Feb 11;384(6):497-511. doi: 10.1056/NEJMoa2023184. Epub 2020 Dec 2.
Zotero 插件